[Ip-health] Scott Gottlieb adds one more high-profile board seat to the post-FDA resume. And it’s another plum assignment – Endpoints News

James Love james.love at keionline.org
Fri Feb 7 05:55:20 PST 2020


The re­volv­ing door out of the FDA led Got­tlieb back to the Amer­i­can
En­ter­prise In­sti­tute and his role as a part­ner at the big VC New
En­ter­prise As­so­ci­ates. Then he quick­ly land­ed on the board of
Pfiz­er and a re­al-world ev­i­dence play­er called Ae­tion. The
Faster­Cures board run by ex-con phil­an­thropist Michael Milken beck­oned.

Now he’s adding Il­lu­mi­na to the ros­ter. The DNA se­quenc­ing
....... snip

More information about the Ip-health mailing list